true join_bam true
- Join BAM
- Events & News
- Job Board
- ME BioScience Day
- Join BAM
- Events & News
- Job Board
- ME BioScience Day
According to EurekaAlert, Novo Biosciences Inc., a spinoff of the MDI Biological Laboratory in Bar Harbor, Maine, has announced that it has received a two-year, $1.5 million Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH) for the development of MSI-1436 as a potential regenerative medicine therapy for the treatment of patients who have suffered an acute heart attack. "We believe MSI-1436 has enormous potential," said Kevin Strange, Ph.D., CEO of Novo Biosciences and president of the MDI Biological Laboratory. "No drug now exists to treat heart attack. Heart disease is the the world's leading killer. In order to advance MSI-1436 into clinical trials, we need to first test its effectiveness in a large animal model. We are deeply grateful to the National Heart, Lung, and Blood Institute for making this possible." Read more
As the BIOME 2017 Annual Conference approaches, we invite you to get to know the professionals who will be delivering the event's feature presentations. Our keynote presenter is Mike Bonney; the Maine Panel is moderated by Norman Moore, PhD of Alere; on the Panel we will have: Catherine Kaczorowski, PhD of Jackson Lab, Todd Keiller of MMCRI, Bryan Briggs of Idexx and Stephen Pelsue, PhD of BBI. Read bios
The MDI Biological Laboratory put 32 interns in research and lab facilities across the state, 20 of the participants supported by Maine INBRE, a network of 13 Maine educational and research institutions led by the laboratory, according to MaineBiz. (...) [T]he summer fellowship program provides undergraduates, 24 of them from Maine colleges, with hands-on research training in an advanced laboratory environment. They work with a faculty mentor and other researches on a biomedical research project, developing professional skills and connections and gaining experience working with the research community. Read full story
According to MBS' press release, the BBI Group, partner to the world’s leading diagnostic and healthcare organisations, has entered into a definitive agreement to acquire the Maine Biotechnology Services, Inc. (MBS) located in Portland, Maine (USA). The acquisition of MBS will expand BBI’s portfolio during a period of expansion and growth. The company provides a range of products to the diagnostic, healthcare, research food sectors globally. MBS will add antibody development to its capability and product range. Read full story
Vets First Choice, the leading provider of technology enabled healthcare solutions for veterinary practices, announced today that its parent company, Direct Vet Marketing, has acquired Roadrunner Pharmacy and Atlas Pharmaceuticals, according to VetsFirstChoice's website. The acquisitions are part of a global initiative to professionalize prescription management services for veterinary practices.Roadrunner Pharmacy is the leading specialty compounding pharmacy, and is known for its innovation, quality, and high service levels. Licensed in all 50 states, Roadrunner employs more than 250 pharmacists, pharmacy technicians, and service professionals. The pharmacy built its reputation on delivering high quality compounded medications, the widest range of proprietary dose forms, and free next-day shipping service. Read more
Portland, July 26, 2017 - The Bioscience Association of Maine is thrilled to announce a new brand identity with a refreshed organization logo. The Bioscience Association of Maine has grown and evolved over the last couple of years and we felt it was time for a change. While the legal name Bioscience Association of Maine will remain unchanged, we have updated the looks and wording of our logo. We wanted the logo to “tell a story” and reflect who we are and what we do as Maine’s only trade group for the life science industry. After long and careful consideration we decided to switch the wording from “Maine Bioscience” to “BIOME” (Bio Maine).
The National Institutes of Health has awarded $20 million in research funding to Portland’s Maine Medical Center and its partners, the University of Southern Maine and the University of Vermont. The five-year grant will be used to establish the Northern New England Clinical and Translational Research Network, “a consortium dedicated to enhancing collaborative biomedical research activities for the improvement of human health,” Maine Medical Center said in a statement. The consortium will join nine other NIH-supported regional networks across the country. Read full story
Secretary of State Matthew Dunlap has certified that nearly 61 percent of voters in last week’s statewide bond referendum approved the borrowing plan. The $50 million bond targets economic development, with $45 million earmarked for infrastructure, equipment and technology upgrades across industry sectors including biotechnology, aquaculture and marine technology, forestry, agriculture, information technology, precision manufacturing and composites. The funding, which will be disbursed as competitive grants, will be administered by the Maine Technology Institute and will be matched with federal or other funds. Read full story
In November, Maine voters will decide whether to spend $10 million of taxpayer money to pay for research aimed at finding a cure for cancer. Many of those voters likely know and love victims of the disease, as supporters of the Question 4 bond question point out. But some urge voters to think beyond the ballot question’s worthy goal to the health of the state’s bottom line. In light of formidable budget constraints — including a looming $70 million shortfall in the state university system — can Maine afford to borrow millions for medical research? Read more
The Maine Cancer Genome Initiative, which is run by the private nonprofit Jackson Laboratory in Bar Harbor, ME, aims to provide up to 1,800 free sequencing tests over the next three or four years, turning the raw DNA data into a report for the participating doctors. It has an $8.5 million philanthropic gift to get started. Read full story
U.S. Senators Susan Collins, the Chairman of the Senate Aging Committee, and Angus King announced today that The Jackson Laboratory in Bar Harbor has been awarded a grant totaling $2,668,127 over five years that will fund studies of the complex processes involved in both healthy aging and Alzheimer’s disease. Read more
Researchers at The Jackson Laboratory and the MDI Biological Laboratory have separately made recent advances in understanding the basics of two of the leading causes of deaths in the United States, colorectal cancer and heart disease, respectively. Read full story
The MDI Biological Laboratory inaugurates its Center for Science Entrepreneurship this week with a new course that will help University of Maine and College of the Atlantic science and engineering undergraduates explore approaches to biomedical research using concepts and tools that promote collaboration across disciplines. Read full story
IDEXX Laboratories Inc., the Westbrook-based provider of diagnostic tests for pets, poultry and livestock, has joined the NASDAQ-100 Index, the company announced this week. The company, which also offers testing solutions for monitoring water quality, announced the move less than three months after entering the S&P 500 Index. Read full story
A new sign in front of MaineGeneral’s Harold Alfond Center for Cancer Care on Old Belgrade Road identifies the center as a home base for genetic technology researchers with The Jackson Laboratory. The outpatient treatment center, which has been operating for almost a decade, is now the home of the Maine Cancer Center Genomics Initiative, led by program Director Andrey Antov and medical Director Dr. Jens Rueter. “Our goal is to create a network of oncology professionals in the state of Maine to provide genomic education so it can be applied successfully in the practice,” Antov said. Read full story
The Bioscience Association of Maine is pleased to announce that all BAM Members are now eligible for significant discounts on UPS shipping services through our partnership with BIO.
The 21st Century Cures Act, passed by the Senate yesterday with overwhelming bipartisan support, is an important victory for biotechnology and medical innovation that will help expedite the development of the next generation medicines, expediate drug approval process, while helping to lower other healthcare costs. The bill provides for $4.8 billion in new funding for the National Institutes of Health; of that, $1.8 billion is reserved for the “cancer moonshot” launched by Vice President Biden to accelerate research in that field. Another $1.6 billion is earmarked for brain diseases including Alzheimer’s. Also included are $500 million in new funding for the Food and Drug Administration and $1 billion in grants to help states deal with opioid abuse, Washington Post reports. Read full story
PORTLAND – November 7, 2016. Bioscience Association of Maine is sponsoring 2 one-week-long summer science camps at Maine School of Science and Mathematics. The scholarships are available to one girl and one boy aged 12-14 who attend middle schools participating in Maine BioScience Day 2016 next week. The camp is located in Limestone, Maine and campers will have an opportunity to explore science, mathematics and technology in a fun way, as well as make new friends and experience a unique summer adventure. Read full story
PORTLAND, Oct 31, 2016 – Bioscience Association of Maine (BAM) is organizing an event, Maine BioScience Day, to inspire young people to pursue a career in one of Maine’s numerous science-based companies. On November 9th, scientists, researchers, and employees from Maine life science companies will be visiting 12 middle schools in Southern Maine to talk about their jobs, show students what their companies do, and raise awareness of the incredible career opportunities this sector offers to Maine students in their proverbial back yards. An estimated 1,750 students will participate in the event. Read full story
ViroStat inc. of Westbrook is in a race with at least one other company to develop an antibody that could be used in diagnostic tests kits detecting the Zika virus, Portland Press Herald reports. Unlike current tests that take weeks to process, the new tests would give patients quick results, potentially within 20 minutes. “It’s a race to be first and a race to see who has the best-quality test,” said Douglas McAllister, the company’s founder and president. Read full story
Boston-based Sappi North America, a worldwide leader in diversified paper and packaging products, with two mills in Maine, has launched a "first of its kind" casting and release paper inspired by the texture of shark skin, which creates surfaces that inhibit bacterial growth without the use of toxic additives or chemicals, MaineBiz reports. The new paper product is to be manufactured at Sappi's Westbrook mill. The Sharklet surface is comprised of millions of microscopic features arranged in a distinct diamond pattern. The structure of the pattern alone inhibits bacteria from attaching, colonizing and forming biofilms and the Sharklet surface contains no toxic additives or chemicals and uses no antibiotics or antimicrobials. Read full story
Mount Desert Island Biological Lab's scientists: Kevin Strange, Voot Yin and their collaborator Michael Zasloff have been awarded a patent for MSI-1436, a potential new heart disease drug that stimulates the repair and regeneration of heart tissue damaged by injuries like a heart attack, according to MaineBiz. This is the first patent for the lab. Prof. Kevin Strange, MDIBL's president says: "The importance of this achievement cannot be overstated. This patent is a critical step forward in our ability to develop new treatments for those who suffer from heart disease (...)". Read full story
Earlier this week officials from Jackson Laboratory were joined by U.S. Sens. Angus King, Susan Collins and other state and local officials to celebrate the kickoff of the retrofitting of a former Lowe's building in Ellsworth, Mainebiz reports. The building is going to serve as a mouse vivarium for breeding research mice that will be sold to biomedical labs across the globe. Read full story
Jackson Laboratory will receive $23.8M in federal research funding from the National Institutes of Health to fund the second phase of a project researching the functions of genes in mice that can be used to discover how diseases affect humans, Mainebiz reports. "Mice and humans share approximately 20,000 genes," JAX Professor and principal investigator of the grant, Robert Braun, said in a prepared statement. "But scientists have little or no data for more than half of these genes." Read full story
A new building is under construction the MDI Biological Laboratory. It will be used as a new training facility for students who come to gain hands on experience in a scientific setting. At the ground breaking ceremony on July 28, students and lab employees signed a steel beam that will be put in to the new building. The facility will be open in the spring of 2017. Read full story
Earlier this month MDI Biological Lab announced a new program supporting pilot projects in R&D areas broadly related to regenerative and aging biology and medicine. The primary objectives of the Pilot Project Program of the MDI Biological Laboratory Center for Comparative Biology of Tissue Repair, Regeneration and Aging are to 1) establish collaborations between COBRE investigators and investigators at other Maine institutions who have basic, clinical and translational research interests broadly related to the fields of regenerative and aging biology, 2) attract additional investigators to the Center to stimulate new programmatic activities that will help build long-term sustainability, and 3) promote utilization of Center bioinformatic and animal resource cores. At least $100,000 of funding is available for scientifically meritorious projects. Learn more here
Animal health company ImmuCell Corp. (NASDAQ: ICCC) of Portland closed its full-year and fourth quarter 2015 with strong sales, which in turn created a backlog of orders for its First Defense product to prevent diarrhea and dehydration in newborn calves. Total sales increased 22% to $2.7 million in the fourth quarter of 2015 ended Dec. 31 compared to $2.2 million in the same period last year. That marked the 14th consecutive quarter of positive sales growth over the last 21 quarters compared to the same quarters the prior years. Net income in Q4 rose to $289,000, or 9 cents per diluted share, versus net income of $131,000, or 4 cents per diluted share, in 4Q2014. Read full story
The Maine Algal Research and Innovation Accelerator (MARIA), is planned to be constructed on Bigelow Laboratory of Ocean Science East Boothbay campus this spring and early summer. The Accelerator will be a roughly 3000-square foot greenhouse and research facility that will grow algae to explore new commercial algal-based products and develop universal algal standards. The initial funding included $5,000 provided by MTI, a seed grant that inspired the whole initiative. The project is also funded through a $100,000 federal grant and a $300,000 loan from the Maine Community Foundation’s Farms, Fisheries and Food Fund. “My hope is that the greenhouse will serve as a flywheel that drives innovation. It will accelerate the process of taking ideas for natural products created using micro and macro algae and turning them into concepts” said Mike Lomas, Director of the National Center for Marine Algae and Microbiota (NCMA) at Bigelow Laboratory. Read full story
Earlier this month the Legislature voted to send a bond proposal to the voters seeking authorization for $50 million to help research and development firms in Maine to invest in infrastructure, equipment and technology upgrades. The bill was signed by Governor Le Page on April 15. If approved by voters, the bond will provide $45 million to the Maine Technology Asset Fund, which is managed by the Maine Technology Institute and provides businesses with funding for capital expenditures like buildings and large machinery, and $5 million to the Maine Venture Fund, which provides venture capital to promising Maine startups. Read full article
Officials from the Bar Harbor-based Jackson Laboratory met with a group of Ellsworth city officials and residents earlier this month to lay out the biomedical firm's plans for its ambitious expansion into the city at a former 140,000-square-foot building that once housed a Lowe's Home Improvement. The plan includes converting the old box store into a mouse vivarium and the conversion is scheduled to take 18 months. Later this month, Sen. Angus King and Sen. Susan Collins revealed that Jackson Lab received a 5.8M grant from USDA for research support. The majority of this sum is going to support Jackson Laboratory's Mouse Genome Database. Read about the expansion plans here and about recent grant for research here.
Two Maine biotech companies have announced news regarding recent changes, Portland Press Herald reports. Scarborough based Fluid Imaging Technologies, BAM member and developer of a specialized device which allows for viewing particles in fluid, just introduced the expansion of their highly popular product, FlowCam, in the 50th country, giving the company a footprint in 7 continents. Shifting gears, another biotech startup company, Biovation of Boothbay is closing its doors. After seven years of developing and marketing innovative anti-microbial fiber products, the startup has laid off employees and put its assets up for sale. “With any risk comes the possibility of failure” said Biovation’s CEO Kerem Durdag about the recent development “It is my strongest belief that we as a state have to culturally get comfortable with the idea of risk if we are to be economically viable and have multiplier (effects) for our kids. And hence we have to see the value of failure. We just have to.” Read full article
Earlier this month the Bioscience Association of Maine appointed three new Board members. The new BAM Board Directors include Dr. Janet Yancey-Wrona, Dr. Dennis Leiner, and Ms. Keri Seitz. The new Board members present tremendous knowledge and experience in the biotech and medical device industry. BAM is very excited to benefit from their unmatched expertise.
The Bioscience Association of Maine is excited to announce a new partnership with UniFirst Corporation, an industry leader in the supply and servicing of uniforms, workwear, and facility products, to add managed uniform, protective clothing, and custom corporate image apparel programs to the exclsusive BIO Business Solutions® offerings available for BAM members.
The Make It In America program administered by Coastal Counties Workforce Inc and their service provider Goodwill Workforce Solutions is accepting applications for their paid internships program. Biotechnology is one of the sectors eligible for paid interns. The program, which is funded through the $1,3M Make It In America Grant awarded to Coastal Counties Workforce Inc. by the US Department of Labor, is available for the following counties: Androscoggin, Cumberland, Kennebec, Knox, Lincoln, Sagadahoc, Waldo, York.
In a piece for Bangor Daily News from Feb 16, Tom Keller, Executive Director of Maine STEM Council proposes establishing Maine Academy of Science and Innovation to help keep young talent in Maine. The purpose of the Academy is to enhance collaboration between multiple research institutions throughout the state with groups supporting economic development and innovation. Academies like this one exist in 48 other states. According to Mr. Keller “There is a need for cross-pollination between various sciences and imagining ways to monetize scientific research. […] The Maine Academy of Science and Innovation could broker these connections.” Read full story here
BAM’s Board of Directors’ President, Bryan Bozsik, wrote an opinion piece on how tax conformity limbo in Augusta is harmful for innovative businesses in Maine, and in effect, hinders healthy job growth. The article was published in Bangor Daily News on February 22, 2016. Read full article here
Immucell, an animal health focused company in Portland is planning an expansion, Mainebiz reports. The manufacturer of Mast Out, a drug that treats mastitis in cows, will build a new facility on the land behind its current location in Portland. The company is also planning additional FDA approvals to bring the animal treatment to the commercial market. Read full story here
Bigelow Laboratory for Ocean Sciences of East Boothbay, Maine, has launched 2 brand new Venture Research Centers that will apply business and project management techniques to its ocean-related research projects to get them into public use faster. One center will focus on research in the Arctic and the other on seafood security. “[T]he centers aim to bridge the gap between what scientists know about the ocean and how that knowledge can be used in policy decisions, for public understanding, for ocean-based products and solutions and ultimately to help boost the state's economy and jobs.” Said Graham Shimmeld, Bigelow Lab’s Executive Director. Read full story
Scientists at Maine Medical Center Research Institute led by Dr. Leif Oxburgh succedeed at growing a tiny piece of kidney in their lab, a scientific achievement that could change the way the world treats kidney disease. This technology could potentially eliminate, or greatly reduce the need for kidney transplants. The minuscule components Oxburgh has grown – held together with silk – could eventually lead to full laboratory-grown organs. Currently the average wait time for those hoping for an organ transplant in the U.S. is 3.6 years. “Some people can’t tolerate the immune therapy, the anti-rejection drugs. This could open up transplants to a huge group of patients who could never get one” said Dr. Oxburgh. Read full story here
The Gulf of Maine Research Institute in Portland is receiving a $6.5 million grant from NASA to create a new educational program focused on science knowledge and problem-solving related to climate change. The new educational content will be delivered to 10,000 5th and 6th graders from Maine who visit GMRI each year. Work at GMRI will begin immediately, and new programming content is expected to be available for the 2018-2019 school year. Read full story
The federal government is giving more than $3.3 million in grants for biomedical research and medical device manufacturing to Jackson Lab and the town of Presque Isle. The Economic Development Administration is giving more than $1.8 million to Jackson Laboratory in Bar Harbor to help build a biomedical facility. It is also giving more than $1.5 million to the city of Presque Isle to develop a city-owned industrial building to accommodate the expansion of an orthodontic and medical device manufacturer Acme Monaco. The grants may help create more than 400 new jobs in the area. Read full story here
A new marine business and research incubator called the New England Ocean Cluster House is being developed on Portland’s waterfront that is modeled after a similar incubator in Reykavik, Iceland. University of New England is co-sponsoring this project, led by Patrick Arnold, the majority owner of the Ocean House. In a written statement, UNE President said "With this new strategic vision at the Marine Science Center, our students focus on the integration of science with the changing nature of coastal tourism, marine policy, aquaculture, fisheries, and entrepreneurship. Experiences afforded them by the New England Ocean Cluster House in research, policy and product development will further them along their career paths and will contribute to the economic vitality of the state and the nation." Read full story
A new program is being launched in Bangor, Maine, to help early stage companies test, improve and figure out how to commercialize their ideas in a short time frame. Scratchpad is a seed accelerator that will allow entrepreneurs fully commit to developing their business fast and with no distractions. The applicants need to have a team of 2-3 people working on their startup full time for a period of 3 months and need to be in Bangor for that time. The awarded will be given funding, daily access to coaches, problem solvers and mentors. The program starts the week of August 31 and the application deadline is August 28. The Scratchpad Accelerator is a University of Maine initiative in collaboration with the Maine Technology Institute. To learn on the application process, please go here. If you are part of an established company and interested in becoming a mentor, please go here.
Seth Berry, a former Maine Legislator and majority leader is transitioning into private sector with Kennebec River Biosciences, Mainebiz reports. Mr. Berry served in the Maine Legislature for eight years (2006–14). In January, Berry was hired by Richmond-based Kennebec River Biosciences as vice president for international business development. "It's really an exciting space, the innovation that's happening in Maine, just as it is in Silicon Valley or the beltway in Boston. Maine is clearly doing some great things" said Mr. Berry. Read full story here
Available through the U.S Department of Labor, the Make It In America Grant provides funds for incumbent workers' training for biotech companies in 8 Maine counties: York, Sagadahoc, Kennebec, Cumberland, Lincoln, Androscoggin, Waldo and Knox. Training must result in an industry-recognized credential within the industry sector for the employee.
The House passed legislation Friday that aims to speed the development of new drugs and medical devices by increasing health research funding and streamlining the approval process for new treatments. The bill, called 21st Century Cures, was cheered by rare across-the-aisle support from politicians, with 230 co-sponsors nearly evenly split between Democrats and Republicans. The pharmaceutical industry, Biotechnology Industry Organization, patient advocacy groups, and medical organizations also support the bill, which calls for an additional $8.75 billion for the National Institutes of Health. Now the debate on whether the benefits of this legislation are worth its risks moves to the Senate. Read full story
Mount Desert Island Biological Laboratory in Bar Harbor is receiving a $392,463 federal grant to support research for treatment of various diseases, including Alzheimer's and Parkinson's. "This funding will support the laboratory as it strives to develop medications and treatments for diseases affecting countless Americans and their families every day." U.S. Sens. Suzan Collins and Angus King said in a joint statement. Read full story
Bioscience Association of Maine (BAM), in collaboration with Bioscience Industry Organization (BIO) is proud to announce that 2 new partners have been added to its cost savings program. The new offerings include savings on executive liability insurance through AON Risk Solutions, and environmental waste services through Clean Harbors. BAM members will now be able to obtain significant discounts on services. Read full story
The Maine Technology Institute (MTI) approved four new awards from its Cluster Initiative Program (CIP) for collaborative projects that boost Maine’s high-potential technology-intensive clusters. The awards were given to TechPlace at Brunswick Landing, the University of Southern Maine Cybersecurity Cluster, the Composites Engineering and Research Lab at Southern Maine Community College and the Forest Bioproducts Research Institute at the University of Maine at Orono. “These projects will enhance collaboration and innovation between public and private sector entities and will lead to the development of new businesses, products, processes, skilled workforce, and jobs.” Said Brian Whitney, MTI’s president. Read full story
The Advanced Medical Technology Association (AdvaMed), the Medical Device Manufacturers Association (MDMA) and the Medical Imaging & Technology Alliance (MITA), a division of National Electrical Manufacturers Association (NEMA), commended the House of Representatives for passing legislation to repeal the medical device excise tax. The legislation, H.R. 160 "The Protect Medical Innovation Act," passed with a vote of 280 to 140 on Thursday, June 18. "For far too long, the medical device tax has stymied advancements in patient care and destroyed high tech manufacturing jobs. Repealing this policy will provide an immediate boost for medical technology innovators to continue solving the pressing challenges in the health care ecosystem. MDMA and the broad coalition of stakeholders who have worked tirelessly to repeal the medical device tax will not rest until we get this accomplished once and for all." said Mark Leahey, President and CEO of MDMA. Read full story here
The Bioscience Association of Maine strongly opposes LD 1422, “An Act To Allow Maine Residents To Personally Import Medications as Permitted under the Federal Food, Drug, and Cosmetic Act”. This legislation, if passed, will present a great risk to the public health of Maine residents and will also open the State of Maine to additional costly and unnecessary litigation. BAM is of the opinion that the legislation outlined in LD 1422 is misguided and we feel inappropriately addresses the issue it purportedly seeks to remedy. Read full statement here
Maine Medical Research Center in Scarborough has attracted acclaimed scientists lately, some bringing grants with them, MaineBiz reports. One scientist is Dr. Peter Brooks, who after years of research on cell and cancer growth at prestigious research institutes around the US, decided to go back to his Maine roots in 2007 and continues his work at MMRCI as a senior researcher and lab head. "I always wanted to do research here in Maine. The biomedical research environment here is growing now. Some 10 to 15 years ago I questioned it,” said Dr. Brooks. Another top class researcher who is joining MMRCI this September is a Harvard Medical School postdoctoral candidate, Dr. Michaela Reagan, whose work focuses on multiple myeloma. Dr. Reagan t, who had never been to Maine prior to accepting the position, is bringing grant money with her which is great news for MMCRI’s PI’s who must raise all of the money to run labs. Read full story
The new business incubator TechPlace is already home to 15 tenants, one day before its Grand Opening on May 28 and 5 months into operations, MaineBiz says. TechPlace, Brunswick Landing’s Technology Accelerator, features 50,000 square foot manufacturing space (enough for 25 companies) and 20,000 square foot office space (room for 23 companies).. The incubator is designed for startups in the aerospace, aviation, biotechnology, renewable energy, composites and advanced materials and IT sectors. Kristine Schuman, business development coordinator for Midcoast Regional Redevelopment Authority, said that “most of the tenants have one-year leases, but they're able to leave at any time with a month's notice and without financial penalty. The benefit is aimed to give startups and early-stage companies a little leeway if things don't go as planned.” Read full story
Three bioscience-focused non-profits collaborate to stimulate Maine’s biotech industry, MaineBiz reports. The new collaborative, known as Life Sciences Group (LSG), includes MDI Biological Laboratory in Salisbury Cove, Bigelow Laboratory for Ocean Sciences in East Boothbay and the Foundation for Blood Research in Scarborough. The idea behind LSG is to attract outside investment and entrepreneurial spirit to Maine. Jane Sheehan, President and CEO of the Foundation for Blood Research, says "The three institutions want to convert science to more of a commercial purpose, keep it in the state and work together as a catalyst for economic growth". Read Full Story
Members of the Bioscience Association of Maine who may need support in a variety of core research areas will find that they do not need to travel out of state to access world-class scientists at very competitive pricing. Todd Keiller, Director of Technology Transfer at MMCRI and Claire Deselle, Executive Director of BAM, discussed the advantages and the opportunity in the following interview.
Maine Biotechonology Services
1037 Forest Ave
Portland, ME 04103